Susquehanna International Group, LLP Cti Biopharma Corp Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 16, 2023	BUY	$4.2 - $6.01 $1 Million - $1.44 Million	239,200 Added 771.61%	270,200 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $2.59 Million - $3.59 Million	-581,200 Reduced 94.94%	31,000 $186,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $2.11 Million - $2.92 Million	393,300 Added 179.67%	612,200 $3.56 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.